Adjuvant dendritic cell (DC)-based vaccine therapy of melanoma patients.

Allogeneic partially HLA-matched dendritic cells (DC) as a vaccine in metastatic renal cell cancer (mRCC): Final analysis of a clinical phase I/II study.

[Dendritic cell-based therapeutic vaccination for acute myeloid leukemia]

Cancer immunotherapy: a paradigm shift for prostate cancer treatment

Successful treatment of advanced ovarian cancer with thermochemotherapy and adjuvant immune therapy

Co-culture of apoptotic breast cancer cells with immature dendritic cells: a novel approach for DC-based vaccination in breast cancer

Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial

Pre-clinical assessment of autologous DC-based therapy in ovarian cancer patients with progressive disease